Abstract:Objective: To analyze the clinical manifestations, pathology, and gene variant characteristics in children with progressive familial intrahepatic cholestasis type 3 (PFIC3). Methods: This retrospective study assessed the clinical manifestations, pathological features, gene variants, and prognosis data of 11 children with PFIC3 hospitalized in the Department of Hepatology, Fifth Medical Center, PLA General Hospital, from January 2015 to December 2022. Panel or whole exome sequencing was performed on the probands, followed by Sanger sequencing for verification within the family. Detected pathogenic variants were compared with known disease databases. Additionally, the new variants were predicted the deleteriousness and protein structure using relevant software to evaluate their pathogenicity. Results: Among the 11 PFIC3 children, 8 were boys and 3 were girls. The age of onset was 3.1 (0.2, 15.6) years. The main complaint of onset was different in the 11 patients;5 of them were abnormal liver function, 3 of them were liver and spleen enlargement, 2 of them were abdominal distension, and 1 of them was jaundice. Alanine aminotransferase, asparate aminotransferase and γ-glutamyltransferase increased in all the patients, which were(113±40), (150±44) and (270±156) U/L respectively. Moreover, direct bilirubin increased in 9 patients, and cholestasis was showed in 8 patients. All patients showed liver fibrosis on imaging, and 8 patients had cirrhosis. The pathological features of 8 cases by liver biopsy were as follows: 8 cases of fibrosis in the portal area, 7 cases of small bile duct hyperplasia, 4 cases of positive copper staining, and 5 cases of cirrhosis. A total of 17 ABCB4 gene variants were detected, including 9 new variants: c.589C>T(p.Q197X), c.1230+1G>A(Splicing), c.2914G>A(P.D972N), c.1058G>A(p.C353Y), c.956G>T(p.G319V), c.473T>A(p.L158Q), c.164T>C(p.L55S), c.2493G>C(p.R831S), and c.1150G>C(p.G384R). All 11 patients were treated with ursodeoxycholic acid and followed up for 5.1(0.6, 7.4) years. Among them, 4 cases of cirrhosis progressed continuously, 3 cases had liver transplantations, and the remaining 4 cases were stable after medical treatment. Conclusions: Children with PFIC3 have early onset, diverse clinical manifestations, rapid progression of fibrotic and cholestasis, as well as poor prognosis. Genetic testing helps to confirm the diagnosis.

Advances in the Study of Familial Intrahepatic Cholestasis

Molecular Findings in Children with Inherited Intrahepatic Cholestasis

[Diagnosis and treatment of hereditary cholestasis]

Familial intrahepatic cholestasis: New and wide perspectives

Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis

Progressive Familial Intrahepatic Cholestasis Related to Mutation of the TJP2 Gene: Recent Advances

Advanced Therapies for Congenital Biliary Tract Malformation: from Bench to Bedside

Genetics in Familial Intrahepatic Cholestasis: Clinical Patterns and Development of Liver and Biliary Cancers: A Review of the Literature

Genetic diagnosis of progressive familial intrahepatic cholestasis type 2

Expanding etiology of progressive familial intrahepatic cholestasis

Novel ATP8B1 Mutation in an Adult Male with Progressive Familial Intrahepatic Cholestasis.

[Analysis of clinical characteristic of children with progressive familial intrahepatic cholestasis type 3]

S2508 Benign Recurrent Intrahepatic Cholestasis Misdiagnosed as Progressive Familial Intrahepatic Cholestasis in Childhood: A Rare Case Report

New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications

Clinical analysis of liver transplantation in progressive familial intrahepatic cholestasis

Diagnostic Yield and Novel Candidate Genes by Next Generation Sequencing in 166 Children with Intrahepatic Cholestasis.

Diagnostic yield and novel candidate genes by exome sequencing in 166 children with intrahepatic cholestasis

Case Report: A rare case of young adult progressive familial intrahepatic cholestasis-type 3 with a novel heterozygous pathogenic variant of ABCB4

[Reappraisal on the clinical diagnosis and treatment of hereditary liver diseases]

Expanding the spectrum of progressive familial intrahepatic cholestasis: A report of 3 cases

ABCB11 gene mutations in Chinese children with progressive intrahepatic cholestasis and low γ glutamyltransferase: ABCB11 mutations in Chinese children